Literature DB >> 25527451

Tumor vasculature and glioma stem cells: Contributions to glioma progression.

Niyati Jhaveri1, Thomas C Chen2, Florence M Hofman3.   

Abstract

Glioblastoma multiforme (GBM), the most malignant of brain tumors, is characterized by extensive vascularization and a high degree of invasion. The current standard of care is not very effective, resulting in tumor recurrence with patients rarely surviving over 2 years. This tumor recurrence is attributed to the presence of chemo and radiation resistant glioma stem cells (GSCs). These cells are associated with vascular niches which regulate GSC self-renewal and survival. Recent studies suggest that while blood vessels support glioma stem cells, these tumor cells in turn may regulate and contribute to the tumor vasculature by transdifferentiating into endothelial cells directly or through the secretion of regulatory growth factors such as vascular endothelial growth factor (VEGF) and hepatoma derived growth factor (HDGF). The relationship between the tumor vasculature and the glioma stem cells is the subject of this review.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Endothelial cells; Glioblastoma multiforme; Glioma stem cells; Vasculature

Mesh:

Year:  2014        PMID: 25527451     DOI: 10.1016/j.canlet.2014.12.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  55 in total

1.  Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Authors:  Corinna Seliger; Anne-Louise Meyer; Kathrin Renner; Verena Leidgens; Sylvia Moeckel; Birgit Jachnik; Katja Dettmer; Ulrike Tischler; Valeria Gerthofer; Lisa Rauer; Martin Uhl; Martin Proescholdt; Ulrich Bogdahn; Markus J Riemenschneider; Peter J Oefner; Marina Kreutz; Arabel Vollmann-Zwerenz; Peter Hau
Journal:  Cell Cycle       Date:  2016-05-10       Impact factor: 4.534

2.  The mechanical and pharmacological regulation of glioblastoma cell migration in 3D matrices.

Authors:  Pranita Kaphle; Yongchao Li; Li Yao
Journal:  J Cell Physiol       Date:  2018-08-21       Impact factor: 6.384

3.  Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.

Authors:  Dou Yu; Omar F Khan; Mario L Suvà; Biqin Dong; Wojciech K Panek; Ting Xiao; Meijing Wu; Yu Han; Atique U Ahmed; Irina V Balyasnikova; Hao F Zhang; Cheng Sun; Robert Langer; Daniel G Anderson; Maciej S Lesniak
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

4.  Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions.

Authors:  Anirudh Sattiraju; Akiva Mintz
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  IFITM3/STAT3 axis promotes glioma cells invasion and is modulated by TGF-β.

Authors:  Hongliang Wang; Feng Tang; Erbao Bian; Yile Zhang; Xinghu Ji; Zhihao Yang; Bing Zhao
Journal:  Mol Biol Rep       Date:  2019-10-21       Impact factor: 2.316

Review 6.  Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors.

Authors:  Rebecca W Pak; Darian H Hadjiabadi; Janaka Senarathna; Shruti Agarwal; Nitish V Thakor; Jay J Pillai; Arvind P Pathak
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-11       Impact factor: 6.200

Review 7.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

8.  PLEKHG5 is a novel prognostic biomarker in glioma patients.

Authors:  Mingyu Qian; Zihang Chen; Shaobo Wang; Xiaofan Guo; Zongpu Zhang; Wei Qiu; Xiao Gao; Jianye Xu; Rongrong Zhao; Hao Xue; Gang Li
Journal:  Int J Clin Oncol       Date:  2019-07-15       Impact factor: 3.402

9.  The Crossroads of Neural Stem Cell Development and Tumorigenesis.

Authors:  Odessa R Yabut; Samuel J Pleasure
Journal:  Opera Med Physiol       Date:  2016-12-25

10.  An orthotopic glioblastoma animal model suitable for high-throughput screenings.

Authors:  Linda Pudelko; Steven Edwards; Mirela Balan; Daniel Nyqvist; Jonathan Al-Saadi; Johannes Dittmer; Ingrid Almlöf; Thomas Helleday; Lars Bräutigam
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.